Baebies Awarded $3M Grant for Pediatric Coagulation Testing
Baebies was recently awarded a Phase IIB SBIR grant from the National Institutes of Health (NIH) for a project to develop a coagulation test panel utilizing very small volumes of blood with a rapid turn-around time. Newborns and young children undergoing cardiac surgery are at a significantly increased risk for a major thrombosis event, and comprehensive hypercoagulability testing is indicated in children who have suffered a major thrombotic or thromboembolic event, or who have a family history of thrombosis.
Currently available coagulation tests are time-consuming and must be ordered individually, which increases the cumulative volume of blood sample required.
This funding enables continued development of a test panel of coagulation analytes on our near-patient digital microfluidic system combining immunoassays, molecular assays, and enzyme activity assays utilizing a small volume of blood sample. Our development is purposefully aimed at a product that generates rapid results from small sample volumes to provide a comprehensive assessment of hypercoagulability risk and address a critical unmet need in pediatric coagulation management.
Our team is strengthened by a long-standing collaboration with a top-rated pediatric cardiac surgeon, Dr. Sitaram Emani, at Boston Children’s Hospital.
[Originally posted by Baebies — July 27, 2020]